.svg)
You are now leaving Astellas.us. The website you are linking to is neither owned nor controlled by Astellas.
Astellas is not responsible for the content or services on this site.
News Releases
Click here to access press releases from Astellas Pharma Inc. located in Tokyo, Japan.
-
Dec 2, 2019Emerging mutations in patients with treatment resistance, from Phase 3 ADMIRAL study, will be focus of oral presentation
-
Dec 2, 2019- Companies to Initiate Phase 3 Trial to Support Global Registrations -
-
Nov 25, 2019Approval based on Asian PREVAIL study of men with metastatic castration-resistant prostate cancer
-
Oct 31, 2019- Results were published online and in the October 31 print edition of the Journal -
Oct 28, 2019- Four innovators awarded $200,000 in total grants and resources following live pitch event to a panel of judges that included celebrity entrepreneur Bill Rancic --
Oct 25, 2019Approval follows accelerated assessment, orphan designation by European Medicines Agency
-
Oct 1, 2019Astellas Commits Nearly $13 Million to Fund Boston-Area Start-Up Innovation in Cell and Gene TherapyFinancial Support for LabCentral Incubators Builds on Astellas' $1 Billion+ Investment in Boston's Life Science Community
-
Sep 30, 2019- Finalists will present their ideas during a live pitch event